Download PDF
CC BY-NC-ND 4.0 · Indian J Plast Surg 2023; 56(06): 507-513
DOI: 10.1055/s-0043-1776011
Original Article

Restoring Quality of Life: Assessing the Impact of Free Flap Reconstruction in Coronavirus Disease 2019-Associated Rhino-Orbital Mucormycosis Patients

Neeraj Rao 
1   Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Anand Agrawal
1   Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Akshay Kapoor
1   Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Vishal Mago
1   Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Madhubari Vathulya
1   Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
,
Debarati Chattopadhyay 
1   Department of Burns and Plastic Surgery, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India
› Author Affiliations
› Further Information
Also available at
   Permissions and Reprints

Abstract

Background In India, between May 5 and July 2021, 41,512 cases and 3,554 deaths due to mucormycosis were reported in coronavirus disease 2019 (COVID-19)-infected patients or COVID-19-recovered patients. COVID-19-associated rhino-orbital mucormycosis (CAROM) has been associated with adverse effects that can affect oral health, vision, and physical as well as emotional functioning. After the radical debridement of CAROM and antifungal therapy, reconstructive surgery should be employed to restore function and aesthetics; however, limited clinical data exist on its potential effect on the quality of life (QOL) of these patients.

Objective Our objective was to assess the QOL among CAROM patients reconstructed with free flap surgery.

Materials and Methods This analysis studied 19 patients of CAROM who had maxillectomy and/or orbital exenteration defects reconstructed with free flaps at a tertiary care center. All these patients were free from any residual disease, as confirmed by tissue biopsy taken from the affected area. The QoL of these patients was assessed 1 week preoperatively and 4 to 6 months postoperatively using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC QLQ-HN43) questionnaire module.

Results There was a statistically significant improvement in 10 out of the total 19 parameters (p < 0.05) which include pain in the mouth, problems opening mouth, speech, swallowing, weight loss, dry mouth and sticky saliva, body image, fear of progression, social contact, and social eating.

Conclusion The EORTC QLQ-HN43 questionnaire module presented a statistically significant improvement in the functional as well as psychological status of the CAROM patients undergoing reconstruction by free flap surgery.

Keywords

COVID-19 - free flap - quality of life - mucormycosis - body image - aesthetics


Publication History

Article published online:
16 October 2023

© 2023. Association of Plastic Surgeons of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223): 497-506
    CrossrefPubMedGoogle Scholar
  • 2 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323 (13) 1239-1242
    CrossrefPubMedGoogle Scholar
  • 3 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733
    CrossrefPubMedGoogle Scholar
  • 4 WHO. Listings of WHO's response to COVID-19. Accessed May 16, 2021 at: https://www.who.int/news/item/29–06–2020-covidtimeline
    Google Scholar
  • 5 Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus 2020; 12 (09) e10726
    CrossrefPubMedGoogle Scholar
  • 6 Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coro- navirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol 2021; 135 (05) 442-447
    CrossrefPubMedGoogle Scholar
  • 7 Garg D, Muthu V, Sehgal IS. et al. Coronavirus disease (COVID-19) associated mucormycosis (CAM): case report and systematic review of literature. Mycopathologia 2021; 186 (02) 289-298
    CrossrefPubMedGoogle Scholar
  • 8 Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia 2020; 185 (04) 599-606
    CrossrefPubMedGoogle Scholar
  • 9 Sarfraz Z, Sarfraz A, Jaiswal V. et al. The past, present and future of COVID-19 associated mucormycosis: a rapid review. J Prim Care Community Health 2022; (e-pub ahead of publication) DOI: 10.1177/21501319221099476.
    CrossrefPubMedGoogle Scholar
  • 10 Rapidis AD. Orbitomaxillary mucormycosis (zygomycosis) and the surgical approach to treatment: perspectives from a maxillofacial surgeon. Clin Microbiol Infect 2009; 15 (Suppl. 05) 98-102
    CrossrefPubMedGoogle Scholar
  • 11 Mekonnen ZK, Ashraf DC, Jankowski T. et al. Acute invasive rhino-orbital mucormycosis in a patient with COVID-19-associated acute respiratory distress syndrome. Ophthal Plast Reconstr Surg 2021; 37 (02) e40-e80
    CrossrefPubMedGoogle Scholar
  • 12 Werthman-Ehrenreich A. Mucormycosis with orbital compartment syndrome in a patient with COVID-19. Am J Emerg Med 2021; 42 (264) 264.e5-264.e8
    CrossrefPubMedGoogle Scholar
  • 13 Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol 2021; 69 (02) 244-252
    CrossrefPubMedGoogle Scholar
  • 14 Cheruvu VPR, Khan MM. Reconstruction in rhino-orbito-cerebral mucormycosis survivors: a systematic review. Eplasty 2022; 22: e20
    PubMedGoogle Scholar
  • 15 Navarro-Perea C, Cañas-Zamarra I, Mencía-Gutiérrez E. et al. Rhino-orbito-cerebral mucormycosis: two cases with amaurosis as presentation, medical surgical management and follow-up. Case Rep Ophthalmol Med 2019; 2019: 4215989
    PubMedGoogle Scholar
  • 16 Dennis SK, Masheeb Z, Abouyared M. Free flap volume changes: can we predict ideal flap size and future volume loss?. Curr Opin Otolaryngol Head Neck Surg 2022; 30 (05) 375-379
    CrossrefPubMedGoogle Scholar
  • 17 Rukadikar C, Rukadikar A, Kishore S. A review on autonomic functional assessment in diabetic patients. Cureus 2023; 15 (02) e34598
    PubMedGoogle Scholar
  • 18 Cordeiro PG, Santamaria E. A classification system and algorithm for reconstruction of maxillectomy and midfacial defects. Plast Reconstr Surg 2000; 105 (07) 2331-2346 , discussion 2347–2348
    CrossrefPubMedGoogle Scholar
  • 19 Accessed September 27, 2023 at: www.eortc.org/app/uploads/sites/2/2018/08/Specimen-HN43English.pdf
  • 20 Rogers SN, Lowe D, McNally D, Brown JS, Vaughan ED. Health-related quality of life after maxillectomy: a comparison between prosthetic obturation and free flap. J Oral Maxillofac Surg 2003; 61 (02) 174-181
    CrossrefPubMedGoogle Scholar
  • 21 Ali A, Fardy MJ, Patton DW. Maxillectomy–to reconstruct or obturate? Results of a UK survey of oral and maxillofacial surgeons. Br J Oral Maxillofac Surg 1995; 33 (04) 207-210
    CrossrefPubMedGoogle Scholar
  • 22 Nayak PS, Goswami P, Kumar AD, Bhaskar P. Quality of life in mucormycosis patients post discharge: a pilot study using a new MQOL-36 questionnaire. Indian J Otolaryngol Head Neck Surg 2023; 75 (02) 397-403
    CrossrefPubMedGoogle Scholar
  • 23 Silberstein E, Krieger Y, Rosenberg N. et al. Facial reconstruction of a mucormy- cosis survivor by free rectus abdominis muscle flap, tissue expansion, and ocular prosthesis. Ophthal Plast Reconstr Surg 2016; 32 (06) e131-e132
    CrossrefPubMedGoogle Scholar
  • 24 Bhatnagar A, Agarwal A. Naso-orbital fistula and socket reconstruction with radial artery forearm flap following orbital mucormycosis. Natl J Maxillofac Surg 2016; 7 (02) 197-200
    CrossrefPubMedGoogle Scholar
  • 25 Odessey E, Cohn A, Beaman K, Schechter L. Invasive mucormycosis of the maxillary sinus: extensive destruction with an indolent presentation. Surg Infect (Larchmt) 2008; 9 (01) 91-98
    CrossrefPubMedGoogle Scholar
  • 26 Lari AR, Kanjoor JR, Vulvoda M, Katchy KC, Khan ZU. Orbital reconstruction following sino-nasal mucormycosis. Br J Plast Surg 2002; 55 (01) 72-75
    CrossrefPubMedGoogle Scholar
  • 27 Rashid HU, Rashid M, Khan N, Ansari SS, Bibi N. Taking a step down on the reconstruction ladder for head and neck reconstruction during the COVID-19 pandemic. BMC Surg 2021; 21 (01) 120
    CrossrefPubMedGoogle Scholar
  • 28 Alfano C, Chiummariello S, Dessy LA, Bistoni G, Scuderi N. Combined mucormycosis and Aspergillosis of the rhinocerebral region. In Vivo 2006; 20 (02) 311-315
    PubMedGoogle Scholar
  • 29 Reinbold C, Derder M, Hivelin M, Ozil C, Al Hindi A, Lantieri L. Using free flaps for reconstruction during infections by mucormycosis: a case report and a structured review of the literature. Ann Chir Plast Esthet 2016; 61 (02) 153-161
    CrossrefPubMedGoogle Scholar